BRKR
NASDAQ
US
Bruker Corporation - Common Stock
$36,76
▲ +$0,68
(+1,88%)
Vol 1.5M
6
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$7.2B
ROE
-1,1%
Margin
-0,6%
D/E
82,59
Beta
1,17
Imbal Hasil Dividen
0,42%
52W
$29–$65
Konsensus Wall Street
22 analis · Apr 20267
Beli Kuat
8
Beli
6
Tahan
1
Jual
0
Jual Kuat
68,2%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,66 | $0,59 | $-0,07 |
| Sep 2025 | $0,34 | $0,45 | +$0,11 |
| Jun 2025 | $0,43 | $0,32 | $-0,11 |
| Mar 2025 | $0,44 | $0,47 | +$0,03 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $979.6M | $801.4M | $797.4M | $860.5M | $977.2M |
| Laba Bersih | — | $13.7M | $17.4M | $7.6M | -$59.6M | $26.0M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 4.4% | 4.4% | 4.4% | 4.4% | -1.1% | -1.1% |
| P/E (TTM) | 78.43 | 64.97 | 65.26 | 74.22 | — | — |
| Net Margin | 0.9% | 2.3% | 2.3% | 2.3% | -0.6% | -0.6% |
| Gross Margin | 45.4% | 48.5% | 48.5% | 48.5% | 48.0% | 48.0% |
| D/E Ratio | 134.99 | 134.99 | 134.99 | 134.99 | 82.59 | 82.59 |
| Current Ratio | 1.61 | 1.61 | 1.61 | 1.61 | 1.85 | 1.85 |
Rasio Utama
ROA (TTM)
-0,3%
P/S (TTM)
2,08
P/B
5,0
EPS (TTM)
$-0,14
CF/Share
$2,86
Pertumbuhan Pendapatan 3T
+11,7%
52W High
$64,64
52W Low
$28,53
$28,53
Rentang 52 Minggu
$64,64
Kesehatan Keuangan
Arus Kas Bebas
$177.8M
Utang Bersih
$1.7B
Kas
$298.8M
Total Utang
$2.0B
Per tanggal Des 31, 2025
Як BRKR виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній
Оцінка BRKR vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
di bawah
rekan
(32,5)
vs Rekan
vs Industri
Nilai wajar
P/S
2,1
▼
46%
di bawah
rekan
(3,8)
vs Rekan
vs Industri
Undervalued
P/B
5,0
▲
34%
di atas
rekan
(3,7)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
0,4%
▼
12%
di bawah
rekan
(0,5%)
vs Rekan
vs Industri
Yield rendah
Прибутковість BRKR vs аналоги Life Sciences Tools & Services
ROE
-1,1%
▲
67%
di atas
rekan
(-3,3%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-0,6%
▲
94%
di atas
rekan
(-9,4%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
48,0%
▲
0%
di atas
rekan
(48,0%)
vs Rekan
vs Industri
Sejajar
ROA
-0,3%
▲
87%
di atas
rekan
(-2,6%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя BRKR vs аналоги Life Sciences Tools & Services
D/E ratio
82,6
▲
126%
di atas
rekan
(36,5)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
1,9
▼
45%
di bawah
rekan
(3,4)
vs Rekan
vs Industri
Likuiditas rendah
Beta
1,2
▼
17%
di bawah
rekan
(1,4)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів BRKR
BRKR
Median rekan
Industri
BRKR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
BRKR vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
ROSENTHAL ROBERT JOHN
Director · Feb 13
4520 shs
PACKER RICHARD A
Director · Feb 13
4520 shs
LINTON WILLIAM A.
Director · Feb 13
4520 shs
ORNELL JOHN A
Director · Feb 13
4520 shs
FRANCIS LAURA A.
Director · Feb 13
4520 shs
PERKINS ADELENE QUIGLEY
Director · Feb 13
4520 shs
ANDERSON BONNIE H
Director · Feb 13
4520 shs
REQUARDT HERMANN FRITZ
Director · Feb 13
4520 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 39,98%FMR, LLC
10,01%
$513.5M
Orbis Allan Gray Ltd
9,79%
$502.7M
Blackrock Inc.
7,21%
$370.0M
Vanguard Group Inc
6,74%
$346.0M
Pallas Capital Advisors Llc
6,23%
$319.7M
Per tanggal Des 31, 2025
Dividen
$0,20
/ tahun
Mar 23, 2026
$0,0500
Des 08, 2025
$0,0500
Sep 23, 2025
$0,0500
Jun 16, 2025
$0,0500
Mar 17, 2025
$0,0500
Des 02, 2024
$0,0500
Agu 30, 2024
$0,0500
Jun 03, 2024
$0,0500